The FDA accepted an NDA for a bictegravir and lenacapavir single-tablet regimen for adults with HIV-1 who have achieved virologic suppression.

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

The US Food and Drug Administration is moving to speed drug development and review by launching real-time clinical trials.

A primary outcome event occurred in 3.4 and 3.0% of patients in the groups receiving balanced fluid and 0.9% saline, respectively; during the 28 days after enrollment, the median number of ...

In 2023, Florida lawmakers unanimously approved expanding KidCare raise the eligibility threshold so that coverage would extend to more than 40,000 children, but the expanded coverage has not taken ...

Physical activity-based interventions may help reduce chronic postsurgical pain, but current evidence is inconclusive.

High-dose recombinant influenza vaccine elicits stronger immune responses against A(H3N2) than standard-dose vaccines in healthy young adults.